GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
U

United Orthopedic 4129.TWO · TWD

Health Care · Taipei Exchange · 🇹🇼 Taiwan

Compare

73.00

+2.38%

Close of 9 Nov 2026, in TWD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in TWD, from our data supplier.

FY2025

Revenue

TWD 5.66bn

FY2016FY2025

Net income

TWD 562.5m

FY2016FY2025

Free cash flow

TWD 264.6m

FY2016FY2025

Shareholders' equity

TWD 4.10bn

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
RevenueTWD 5.66bnTWD 4.65bnTWD 3.94bnTWD 3.16bnTWD 2.57bnTWD 2.35bnTWD 2.45bnTWD 2.32bnTWD 1.97bnTWD 1.42bn
Gross profitTWD 4.40bnTWD 3.62bnTWD 2.77bnTWD 2.12bnTWD 1.63bnTWD 1.45bnTWD 1.55bnTWD 1.46bnTWD 1.32bnTWD 918.4m
Research and developmentTWD 262.5mTWD 220.5mTWD 185.0mTWD 167.3mTWD 143.7mTWD 155.1mTWD 188.3mTWD 200.5mTWD 198.7mTWD 161.2m
Operating income—TWD 624.0mTWD 543.3mTWD 341.6mTWD 161.4mTWD 89.9mTWD 81.4mTWD 84.8mTWD 161.9mTWD 159.7m
Net incomeTWD 562.5mTWD 456.4mTWD 384.2mTWD 221.5mTWD 52.3mTWD 101.8mTWD 88.6mTWD 127.6mTWD 130.3mTWD 146.6m
Diluted earnings per share5.834.744.012.840.671.271.101.491.722.00

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assetsTWD 7.82bnTWD 7.04bnTWD 6.42bnTWD 5.62bnTWD 5.24bnTWD 5.59bnTWD 5.24bnTWD 4.85bnTWD 4.30bnTWD 2.96bn
Cash and short-term investments——TWD 457.9mTWD 411.5mTWD 638.7mTWD 867.4mTWD 539.1mTWD 528.5mTWD 401.4mTWD 477.9m
Total liabilitiesTWD 3.62bnTWD 3.09bnTWD 2.82bnTWD 2.53bnTWD 2.42bnTWD 2.66bnTWD 2.31bnTWD 2.60bnTWD 2.08bnTWD 1.15bn
DebtTWD 812.6mTWD 1.86bnTWD 1.63bnTWD 1.57bnTWD 1.72bnTWD 1.92bnTWD 1.61bnTWD 1.96bnTWD 1.37bnTWD 638.7m
Shareholders' equityTWD 4.10bnTWD 3.85bnTWD 3.50bnTWD 2.99bnTWD 2.72bnTWD 2.82bnTWD 2.83bnTWD 2.23bnTWD 2.20bnTWD 1.77bn
Shares outstanding96m96m96m78m78m80m80m85m76m73m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operationsTWD 1.03bnTWD 717.3mTWD 398.4mTWD 340.8mTWD 334.6mTWD 481.7mTWD 492.4mTWD 12.4mTWD 2.9mTWD 179.0m
Capital spending−TWD 761.2m−TWD 589.3m−TWD 557.5m−TWD 386.2m−TWD 227.2m−TWD 231.8m−TWD 299.4m−TWD 386.2m−TWD 584.4m−TWD 394.5m
Free cash flowTWD 264.6mTWD 128.0m−TWD 159.1m−TWD 45.4mTWD 107.4mTWD 249.9mTWD 193.0m−TWD 373.8m−TWD 581.5m−TWD 215.5m
Dividends paid−TWD 385.9m−TWD 385.9m−TWD 200.6m—−TWD 88.8m−TWD 69.1m−TWD 160.9m−TWD 100.4m−TWD 99.6m−TWD 114.8m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
RevenueTWD 1.57bnTWD 1.49bnTWD 1.52bnTWD 1.49bnTWD 1.35bnTWD 1.30bnTWD 1.32bnTWD 1.13bn
Gross profitTWD 1.23bnTWD 1.19bnTWD 1.19bnTWD 1.13bnTWD 1.03bnTWD 1.05bnTWD 1.01bnTWD 898.5m
Operating incomeTWD 186.3m—TWD 175.8m———TWD 173.4m—
Net incomeTWD 138.8mTWD 87.8mTWD 130.9mTWD 194.1mTWD 46.6mTWD 190.8mTWD 122.0mTWD 138.4m
Diluted earnings per share1.440.911.362.010.481.981.271.44
Cash from operationsTWD 51.0mTWD 138.0mTWD 223.0mTWD 328.0mTWD 287.0mTWD 186.0mTWD 293.0mTWD 222.0m
Capital spending−TWD 185.0m−TWD 221.0m−TWD 251.0m−TWD 171.0m−TWD 211.0m−TWD 125.0m−TWD 109.0m−TWD 203.0m
Free cash flow−TWD 134.0m−TWD 83.0m−TWD 28.0mTWD 157.0mTWD 76.0mTWD 61.0mTWD 184.0mTWD 19.0m
Total assetsTWD 8.51bnTWD 8.26bnTWD 7.82bnTWD 7.46bnTWD 7.19bnTWD 7.20bnTWD 7.04bnTWD 6.85bn
DebtTWD 772.1mTWD 792.0mTWD 812.6mTWD 866.7mTWD 914.4mTWD 317.5mTWD 357.0mTWD 398.8m
Shareholders' equityTWD 3.90bnTWD 4.21bnTWD 4.10bnTWD 3.92bnTWD 3.68bnTWD 4.08bnTWD 3.85bnTWD 3.73bn

Financial ratios

Data as of 5 Oct 2026

FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Gross margin77.8%87.7%70.1%67.1%63.4%61.6%—
Operating margin13.9%13.4%13.8%10.8%6.3%3.8%—
Net margin9.9%9.8%9.7%7.0%2.0%4.3%—
Return on equity13.7%11.8%11.0%7.4%1.9%3.6%—
Return on assets7.2%6.5%6.0%3.9%1.0%1.8%—
Free cash flow yield—16.5%12.2%11.3%8.7%10.8%12.0%
Revenue growth21.5%18.0%24.8%22.9%9.6%-4.2%—
Earnings growth23.2%18.8%73.4%323.8%-48.7%15.0%—
Current ratio1.72x1.55x1.79x1.52x1.25x1.56x—
Debt to equity0.20x0.09x0.42x0.46x0.56x0.61x—
Equity ratio52.4%54.7%54.5%53.3%51.9%50.5%—
Interest coverage17.12x14.45x12.31x14.17x9.15x2.86x—
R&D as a share of sales4.6%4.7%4.7%5.3%5.6%6.6%—
Buybacks as a share of market value—-0.6%-22.5%0.4%2.5%0.0%—

Growth per year

Compound annual rate

3 years5 years10 years
Revenue21.4%19.2%15.0%
Net income36.4%40.8%15.4%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin77.8%74.1%71.6%69.7%
Net margin9.9%9.3%8.0%7.5%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings19.219.521.216.947.229.240.330.137.329.4
Price to sales1.91.92.11.21.01.31.51.62.53.0

Dividends and splits

Per share, in the currency the company pays

Paid for 3 years. Last went ex-dividend on 23 Jul 2026.

FY2026FY2025FY2024FY2023
Paid in the year4.504.004.0032.275

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.